Diferencia entre revisiones de «Template:Cholecystitis Antibiotics»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
''Coverage is targeted at E. coli, Enterococcus, Bacteroides, and Clostridium (anerobic) | ''Coverage is targeted at [[E. coli]], [[Enterococcus]], [[Bacteroides]], and [[Clostridium]] (anerobic) | ||
====Uncomplicated Cholecystitis==== | ====Uncomplicated Cholecystitis==== | ||
*[[Ertapenem]] 1g IV once daily OR | *[[Ertapenem]] 1g IV once daily OR | ||
Revisión del 01:58 3 abr 2019
Coverage is targeted at E. coli, Enterococcus, Bacteroides, and Clostridium (anerobic)
Uncomplicated Cholecystitis
- Ertapenem 1g IV once daily OR
- Metronidazole 500mg IV q8hrs PLUS
- Ciprofloxacin 400mg IV q12 hrs OR
- Levofloxacin 750mg IV q24hrs OR
- Ceftriaxone 1g IV q24hrs
Complicated
Complicated disease such as severe sepsis or hemodynamic instability
- Vancomycin 15-20mg/kg PLUS any of the following options
Options:
- Metronidazole 500mg IV q8hrs PLUS Ciprofloxacin 400mg IV q12hrs
- Piperacillin/Tazobactam 4.5g IV q8hrs
- Imipenem/Cilastin 500mg IV q6hrs
- Doripenem 500mg IV q8hrs
- Meropenem 1g IV q8hrs